We just speculate that those withanti-CD38 autoantibodies should show lower frequencies of diabetic nephropathy,and other vascular complications in long-term follow-up studies due to betterglycemic control and increased ADPRCA reflecting less maturated PBMCs. The gene discussed is CD38; the disease is diabetic kidney disease.